接口广告
摩熵化学
数据开放平台 数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N'-[(Z)-(3-hydroxyphenyl)methylideneamino]pyridine-2-carboximidamide

中文名称
——
中文别名
——
英文名称
N'-[(Z)-(3-hydroxyphenyl)methylideneamino]pyridine-2-carboximidamide
英文别名
——
N'-[(Z)-(3-hydroxyphenyl)methylideneamino]pyridine-2-carboximidamide化学式
CAS
——
化学式
C13H12N4O
mdl
——
分子量
240.26
InChiKey
PEWSUTOUDLXWHN-SXGWCWSVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    83.9
  • 氢给体数:
    2
  • 氢受体数:
    4

文献信息

  • INDUCTION AND/OR MAINTENANCE OF TUMOR DORMANCY BY DISRUPTION OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-INTEGRIN INTERACTION
    申请人:Ossowski Liliana
    公开号:US20100249184A1
    公开(公告)日:2010-09-30
    The present invention relates to a method of inducing cancer cells into dormancy and treating cancer in a subject. This method involves administering to a subject an effective amount of a compound that disrupts interaction between urokinase plasminogen activator receptor and integrin, thereby including cancer cells into dormancy and treating cancer in the subject. Also disclosed is a method of disrupting interaction between integrin and urokinase plasminogen activator receptor on cancer cells. The present invention also relates to a method of screening for compounds effective in inducing tumor dormancy and treating cancer in a subject.
查看更多